Clinical trial
A Placebo-Controlled Study of Mirtazapine for PTSD
NCT00302107 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00302107 |
|---|---|
| Title | A Placebo-Controlled Study of Mirtazapine for PTSD |
| Official title | A Placebo-Controlled Study of Mirtazapine for PTSD in OIF/OEF Veterans |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anxiety, PTSD |
| Intervention type | Drug |
| Interventions | Mirtazapine, Placebo |
| Enrollment | 78 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2011 |
| Completion | Jun 1, 2012 |
| First posted | Mar 13, 2006 |
| Last update posted | Nov 26, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: